MEG
BSX icon

Millstone Evans Group’s Boston Scientific BSX Stock Holding History

Millstone Evans Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.4K Hold
432
– – 0.01% 509
2026
Q1 		$27.1K Hold
432
– – 0.02% 441
2025
Q4 		$41.2K Hold
432
– – 0.02% 364
2025
Q3 		$42.2K Sell
432
-148
-26% -$15.3K 0.03% 339
2025
Q2 		$62.3K Hold
580
– – 0.04% 266
2025
Q1 		$58.5K Hold
580
– – 0.04% 270
2024
Q4 		$51.8K Buy
+580
New +$51.1K 0.04% 285

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Millstone Evans Group's BSX Position: Q2 2026 in Review

Millstone Evans Group held its Boston Scientific (BSX) position steady in Q2 2026 at 432 shares worth $18.4K. The position accounts for 0.01% of the portfolio, ranked #509.

Millstone Evans Group first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $62.3K in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Millstone Evans Group held 432 shares of Boston Scientific worth $18.4K as of Q2 2026.
  • Millstone Evans Group left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up 0.01% of Millstone Evans Group's portfolio in Q2 2026, its #509 holding.
  • Millstone Evans Group first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
  • Millstone Evans Group's Boston Scientific position peaked at $62.3K in Q2 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Millstone Evans Group's 13F filing for Q2 2026, filed 11 Aug 2026.